Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study
Authors:
Open Access
- 22 March 2022
- journal article
- research article
- Published by Springer Nature in BMC Primary Care
- Vol. 23 (1) , 1-9
Abstract
Background: Deprescribing, or the intentional discontinuation or dose-reduction of medications, is an approach to reduce harms associated with inappropriate medication use. We sought to determine how direct-to-patient educational materials impacted patient-provider discussion about and deprescribing of potentially inappropriate medications. Methods: We conducted a pre-post pilot trial, using an historical control group, at an urban VA medical center. We included patients in one of two cohorts: 1) chronic proton pump inhibitor users (PPI), defined as use of any dose for 90 consecutive days, or 2) patients at hypoglycemia risk, defined by diabetes diagnosis; prescription for insulin or sulfonylurea; hemoglobin A1c < 7%; and age ≥ 65 years, renal insufficiency, or cognitive impairment. The intervention consisted of mailing medication-specific patient-centered EMPOWER (Eliminating Medications Through Patient Ownership of End Results) brochures, adapted to a Veteran patient population, two weeks prior to scheduled primary care appointments. Our primary outcome – deprescribing – was defined as clinical documentation of target medication discontinuation or dose-reduction. Our secondary outcome was documentation of a discussion about the target medication (yes/possible vs. no/absent). Covariates included age, sex, race, specified comorbidities, medications, and utilization. We used chi-square tests to examine the association of receiving brochures with each outcome. Results: The 348 subjects (253 intervention, 95 historical control) were primarily age ≥ 65 years, white, and male. Compared to control subjects, intervention subjects were more likely to have deprescribing (36 [14.2%] vs. 4 [4.2%], p = 0.009) and discussions about the target medication (31 [12.3%] vs. 1 [1.1%], p = 0.001). Conclusions: Targeted mailings of EMPOWER brochures temporally linked to a scheduled visit in primary care clinics are a low-cost, low-technology method associated with increases in both deprescribing and documentation of patient-provider medication discussions in a Veteran population. Leveraging the potential for patients to initiate deprescribing discussions within clinical encounters is a promising strategy to reduce drug burden and decrease adverse drug effects and harms.Keywords
All Related Versions
Funding Information
- Health Services Research and Development (PPO 18-228)
This publication has 46 references indexed in Scilit:
- Increased Mortality of Patients With Diabetes Reporting Severe HypoglycemiaDiabetes Care, 2012
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- Overutilization of proton-pump inhibitors: what the clinician needs to knowTherapeutic Advances in Gastroenterology, 2012
- Emergency Hospitalizations for Adverse Drug Events in Older AmericansNew England Journal of Medicine, 2011
- Medication quality and quality of life in the elderly, a cohort studyHealth and Quality of Life Outcomes, 2011
- Combined life satisfaction of persons with stroke and their caregivers: associations with caregiver burden and the impact of strokeHealth and Quality of Life Outcomes, 2011
- Severe Hypoglycemia and Risks of Vascular Events and DeathNew England Journal of Medicine, 2010
- Measuring patient-centered communication in Patient–Physician consultations: Theoretical and practical issuesSocial Science & Medicine, 2005
- Adverse Drug Events in Ambulatory CareNew England Journal of Medicine, 2003
- Andragogy and Self‐Directed Learning: Pillars of Adult Learning TheoryNew Directions for Adult and Continuing Education, 2001